User: Guest

NEUROSCIENCE ANTIBODIES AND ASSAYS

Global Market Trajectory & Analytics

MCP13582

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

1587
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

286
Interactions with Platform & by Email

PARTICIPANTS

63
Unique # Participated

VALIDATIONS

28
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

SEPTEMBER 2020

TABLES

153

PAGES

225

EDITION

9

PRICE

USD $4950


Amid the COVID-19 crisis, the global market for Neuroscience Antibodies and Assays estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$5.1 Billion by 2027, growing at aCAGR of 8.8% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 9.2% CAGR and reach US$3.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 7.8% CAGR for the next 7-year period.
The Neuroscience Antibodies and Assays market in the U.S. is estimated at US$831.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$879.3 Million by the year 2027 trailing a CAGR of 8.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 7.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.We bring years of research experience to this 9th edition of our report. The 225-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abcam PLC; BioLegend, Inc.; Bio-Rad Laboratories, Inc.; Cell Signaling Technology, Inc.; F. Hoffmann-La Roche AG; GenScript Biotech Corporation; Merck KgaA; Rockland Immunochemicals, Inc.; Santa Cruz Biotechnology, Inc.; Siemens Healthineers; Tecan Group Ltd.; Thermo Fisher Scientific, Inc.
» End-Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers) » Product (Consumables, Instruments) » Technology (Immunochemistry/Immunoassays, Molecular Diagnostics, Clinical Chemistry, Other Technologies)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Global Competitor Market Shares
Neuroscience Antibodies and Assays Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Neuroscience Antibodies and Assays Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
Neuroscience Antibodies and Assays Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019
Neuroscience Antibodies and Assays Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
Consumables (Product) World Market by Region/Country in US$ Million: 2020 to 2027
Consumables (Product) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
Consumables (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Instruments (Product) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
Instruments (Product) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019
Instruments (Product) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
Immunochemistry/Immunoassays (Technology) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
Immunochemistry/Immunoassays (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019
Immunochemistry/Immunoassays (Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
Molecular Diagnostics (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
Molecular Diagnostics (Technology) Market Historic Review by Region/Country in US$ Million: 2012 to 2019
Molecular Diagnostics (Technology) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
Clinical Chemistry (Technology) World Market by Region/Country in US$ Million: 2020 to 2027
Clinical Chemistry (Technology) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019
Clinical Chemistry (Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
Other Technologies (Technology) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
Other Technologies (Technology) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to 2019
Other Technologies (Technology) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS 2027
Pharmaceutical & Biotechnology Companies (End-Use) Global Opportunity Assessment in US$ Million by Region/Country: 2020-2027
Pharmaceutical & Biotechnology Companies (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2012-2019
Pharmaceutical & Biotechnology Companies (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
Academic & Research Institutes (End-Use) Worldwide Sales in US$ Million by Region/Country: 2020-2027
Academic & Research Institutes (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2012-2019
Academic & Research Institutes (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
Hospitals & Diagnostic Centers (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2020-2027
Hospitals & Diagnostic Centers (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2012-2019
Hospitals & Diagnostic Centers (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Neuroscience Antibodies and Assays Market Share (in %) by Company: 2019 & 2025
United States Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Product: 2020 to 2027
Neuroscience Antibodies and Assays Market in the United States by Product: A Historic Review in US$ Million for 2012-2019
United States Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2012 VS 2020 VS 2027
Neuroscience Antibodies and Assays Market in US$ Million in the United States by Technology: 2020-2027
United States Neuroscience Antibodies and Assays Market Retrospective Analysis in US$ Million by Technology: 2012-2019
United States Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
United States Neuroscience Antibodies and Assays Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027
Neuroscience Antibodies and Assays Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019
Neuroscience Antibodies and Assays Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027
CANADA
Canadian Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2020 to 2027
Canadian Neuroscience Antibodies and Assays Historic Market Review by Product in US$ Million: 2012-2019
Neuroscience Antibodies and Assays Market in Canada: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027
Neuroscience Antibodies and Assays Market Analysis in Canada in US$ Million by Technology: 2020-2027
Neuroscience Antibodies and Assays Market in Canada: Historic Review in US$ Million by Technology for the Period 2012-2019
Canadian Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
Canadian Neuroscience Antibodies and Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
Neuroscience Antibodies and Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
Canadian Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
JAPAN
Japanese Market for Neuroscience Antibodies and Assays: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020-2027
Neuroscience Antibodies and Assays Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2012-2019
Japanese Neuroscience Antibodies and Assays Market Share Analysis by Product: 2012 VS 2020 VS 2027
Japanese Medium & Long-Term Outlook for Neuroscience Antibodies and Assays Market in US$ Million by Technology: 2020-2027
Neuroscience Antibodies and Assays Market in Japan in US$ Million by Technology: 2012-2019
Japanese Neuroscience Antibodies and Assays Market Percentage Share Distribution by Technology: 2012 VS 2020 VS 2027
Japanese Demand Estimates and Forecasts for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2020 to 2027
Japanese Neuroscience Antibodies and Assays Market in US$ Million by End-Use: 2012-2019
Neuroscience Antibodies and Assays Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027
CHINA
Chinese Neuroscience Antibodies and Assays Market Growth Prospects in US$ Million by Product for the Period 2020-2027
Neuroscience Antibodies and Assays Historic Market Analysis in China in US$ Million by Product: 2012-2019
Chinese Neuroscience Antibodies and Assays Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027
Neuroscience Antibodies and Assays Market Estimates and Forecasts in China in US$ Million by Technology: 2020-2027
Chinese Neuroscience Antibodies and Assays Retrospective Market Scenario in US$ Million by Technology: 2012-2019
Neuroscience Antibodies and Assays Market in China: Percentage Share Analysis by Technology for 2012, 2020, and 2027
Chinese Demand for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2020 to 2027
Neuroscience Antibodies and Assays Market Review in China in US$ Million by End-Use: 2012-2019
Chinese Neuroscience Antibodies and Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Neuroscience Antibodies and Assays Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Neuroscience Antibodies and Assays Market Demand Scenario in US$ Million by Region/Country: 2020-2027
Neuroscience Antibodies and Assays Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019
European Neuroscience Antibodies and Assays Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
European Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2020-2027
Neuroscience Antibodies and Assays Market in Europe in US$ Million by Product: A Historic Review for the Period 2012-2019
European Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2012 VS 2020 VS 2027
European Neuroscience Antibodies and Assays Market Assessment in US$ Million by Technology: 2020-2027
European Neuroscience Antibodies and Assays Historic Market Review in US$ Million by Technology: 2012-2019
Neuroscience Antibodies and Assays Market in Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and 2027
European Neuroscience Antibodies and Assays Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
Neuroscience Antibodies and Assays Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
European Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
FRANCE
Neuroscience Antibodies and Assays Market in France by Product: Estimates and Projections in US$ Million for the Period 2020-2027
French Neuroscience Antibodies and Assays Historic Market Scenario in US$ Million by Product: 2012-2019
French Neuroscience Antibodies and Assays Market Share Analysis by Product: 2012 VS 2020 VS 2027
French Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Technology: 2020-2027
French Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Technology: 2012-2019
French Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
Neuroscience Antibodies and Assays Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027
French Neuroscience Antibodies and Assays Historic Market Review in US$ Million by End-Use: 2012-2019
French Neuroscience Antibodies and Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
GERMANY
Neuroscience Antibodies and Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2020-2027
German Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Product: 2012-2019
German Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2012 VS 2020 VS 2027
German Neuroscience Antibodies and Assays Latent Demand Forecasts in US$ Million by Technology: 2020-2027
Neuroscience Antibodies and Assays Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2012-2019
German Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
Neuroscience Antibodies and Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027
German Neuroscience Antibodies and Assays Market in Retrospect in US$ Million by End-Use: 2012-2019
Neuroscience Antibodies and Assays Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027
ITALY
Italian Neuroscience Antibodies and Assays Market Growth Prospects in US$ Million by Product for the Period 2020-2027
Neuroscience Antibodies and Assays Historic Market Analysis in Italy in US$ Million by Product: 2012-2019
Italian Neuroscience Antibodies and Assays Market by Product: Percentage Breakdown of Sales for 2012, 2020, and 2027
Neuroscience Antibodies and Assays Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020-2027
Italian Neuroscience Antibodies and Assays Retrospective Market Scenario in US$ Million by Technology: 2012-2019
Neuroscience Antibodies and Assays Market in Italy: Percentage Share Analysis by Technology for 2012, 2020, and 2027
Italian Demand for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2020 to 2027
Neuroscience Antibodies and Assays Market Review in Italy in US$ Million by End-Use: 2012-2019
Italian Neuroscience Antibodies and Assays Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027
UNITED KINGDOM
United Kingdom Market for Neuroscience Antibodies and Assays: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020-2027
Neuroscience Antibodies and Assays Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2012-2019
United Kingdom Neuroscience Antibodies and Assays Market Share Analysis by Product: 2012 VS 2020 VS 2027
United Kingdom Medium & Long-Term Outlook for Neuroscience Antibodies and Assays Market in US$ Million by Technology: 2020-2027
Neuroscience Antibodies and Assays Market in the United Kingdom in US$ Million by Technology: 2012-2019
United Kingdom Neuroscience Antibodies and Assays Market Percentage Share Distribution by Technology: 2012 VS 2020 VS 2027
United Kingdom Demand Estimates and Forecasts for Neuroscience Antibodies and Assays in US$ Million by End-Use: 2020 to 2027
United Kingdom Neuroscience Antibodies and Assays Market in US$ Million by End-Use: 2012-2019
Neuroscience Antibodies and Assays Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027
REST OF EUROPE
Rest of Europe Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2020-2027
Neuroscience Antibodies and Assays Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2012-2019
Rest of Europe Neuroscience Antibodies and Assays Market Share Breakdown by Product: 2012 VS 2020 VS 2027
Rest of Europe Neuroscience Antibodies and Assays Market Assessment in US$ Million by Technology: 2020-2027
Rest of Europe Neuroscience Antibodies and Assays Historic Market Review in US$ Million by Technology: 2012-2019
Neuroscience Antibodies and Assays Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and 2027
Rest of Europe Neuroscience Antibodies and Assays Addressable Market Opportunity in US$ Million by End-Use: 2020-2027
Neuroscience Antibodies and Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019
Rest of Europe Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
ASIA-PACIFIC
Neuroscience Antibodies and Assays Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2020-2027
Asia-Pacific Neuroscience Antibodies and Assays Historic Market Scenario in US$ Million by Product: 2012-2019
Asia-Pacific Neuroscience Antibodies and Assays Market Share Analysis by Product: 2012 VS 2020 VS 2027
Asia-Pacific Neuroscience Antibodies and Assays Market Estimates and Projections in US$ Million by Technology: 2020-2027
Asia-Pacific Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Technology: 2012-2019
Asia-Pacific Neuroscience Antibodies and Assays Historic Market Analysis in US$ Million by Technology: 2012 VS 2020 VS 2027
Neuroscience Antibodies and Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027
Asia-Pacific Neuroscience Antibodies and Assays Historic Market Review in US$ Million by End-Use: 2012-2019
Asia-Pacific Neuroscience Antibodies and Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027
REST OF WORLD
Rest of World Neuroscience Antibodies and Assays Market Estimates and Forecasts in US$ Million by Product: 2020 to 2027
Rest of World Neuroscience Antibodies and Assays Historic Market Review by Product in US$ Million: 2012-2019
Neuroscience Antibodies and Assays Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2012, 2020, and 2027
Neuroscience Antibodies and Assays Market Analysis in Rest of World in US$ Million by Technology: 2020-2027
Neuroscience Antibodies and Assays Market in Rest of World: Historic Review in US$ Million by Technology for the Period 2012-2019
Rest of World Neuroscience Antibodies and Assays Market Share Breakdown by Technology: 2012 VS 2020 VS 2027
Rest of World Neuroscience Antibodies and Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027
Neuroscience Antibodies and Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019
Rest of World Neuroscience Antibodies and Assays Market Share Analysis by End-Use: 2012 VS 2020 VS 2027
Total Companies Profiled : 7

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

General queries: Info411@StrategyR.com